DMKJ
TGTX icon

David M. Knott Jr’s TG Therapeutics TGTX Stock Holding History

David M. Knott Jr’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67M Sell
66,839
-23,162
-26% -$948K 1.94% 14
2026
Q1 		$2.99M Buy
90,001
+45,001
+100% +$1.34M 1.78% 17
2025
Q4 		$1.34M Buy
+45,000
New +$1.47M 0.62% 26
2022
Q1 		– Sell
-33,592
Closed -$638K – 148
2021
Q4 		$638K Buy
+33,592
New +$872K 0.22% 64

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

David M. Knott Jr's TGTX Position: Q2 2026 in Review

David M. Knott Jr reduced its TG Therapeutics (TGTX) stake by 26% in Q2 2026, selling an estimated $948K and leaving 66,839 shares worth $3.67M. The position accounts for 1.94% of the portfolio, ranked #14.

David M. Knott Jr first reported a position in TGTX in Q4 2021 and has held it in 4 quarters since. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • David M. Knott Jr held 66,839 shares of TG Therapeutics worth $3.67M as of Q2 2026.
  • David M. Knott Jr sold 23,162 TG Therapeutics shares in Q2 2026, an estimated $948K.
  • TG Therapeutics made up 1.94% of David M. Knott Jr's portfolio in Q2 2026, its #14 holding.
  • David M. Knott Jr first reported a position in TG Therapeutics in Q4 2021 and has held it in 4 quarters since.
  • 428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.